{"nct_id":"NCT02083185","title":"A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2014-03-26","start_date_type":"ACTUAL","primary_completion_date":"2016-01-01","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}